Peptide-Derived Protease-Activated Receptor-1 (PAR-1) Antagonists

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 1, Iss. 1, 2003-03 ,pp. : 1-11

Bentham Science Publishers

Access to resources Recommend Favorite

Similarities and Differences between Angiotensin II Type 1 Receptor Antagonists

By Alberto Corsini  

High Blood Pressure & Cardiovascular Prevention, Vol. 11, Iss. 3, 2004-01 ,pp. : 117-121

Adis International

Access to resources Recommend Favorite

Discovery of Potent Peptide-Mimetic Antagonists for the Human Thrombin Receptor, Protease-Activated Receptor-1 (PAR-1)

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 1, Iss. 1, 2003-03 ,pp. : 13-36

Bentham Science Publishers

Access to resources Recommend Favorite

TRANSCEND Aftermath: Angiotensin II Type 1 Receptor Antagonists (Angiotensin Receptor Blockers) at the Clinical Crossroad

By Volpe Massimo  

High Blood Pressure & Cardiovascular Prevention, Vol. 16, Iss. 1, 2009-05 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Prolactin receptor antagonists

By Benson Kuo Chiaoyun   Coss Djurdjica   Walker Ameae  

Endocrine Journal, Vol. 9, Iss. 2, 1998-10 ,pp. : 121-131

Humana Press, Inc

Access to resources Recommend Favorite